论文部分内容阅读
对２４０例有症状的前列腺增生症（ＢＰＨ）患者分别行经尿道前列腺电汽化术（ＴＶＰ）和经尿道前列腺电切术（ＴＵＲＰ）。结果显示：１２０例ＴＶＰ手术者，前列腺症状评分（ＩＰＳＳ）从术前的２０．９下降至术后３个月的５．１（Ｐ＜０．００１），最大尿流率由１０．６ｍｌ／ｓ上升至１９．２ｍｌ／ｓ（Ｐ＜０．０１）。ＴＵＲＰ组１２０例，ＩＰＳＳ从术前的２１．２下降至术后３个月的５．２（Ｐ＜０．００１），最大尿流率由１０．２ｍｌ／ｓ上升至１９．４ｍｌ／ｓ（Ｐ＜０．０１），两组比较无显著差异性（Ｐ＞０．０５）。平均留置导尿管时间：ＴＶＰ组２６．５小时，ＴＵＲＰ组５０．７小时，有显著性差异（Ｐ＜０．０１）。术后阳萎发生率：ＴＶＰ组２．４％，ＴＵＲＰ组１４．５％（Ｐ＜０．０５）。ＴＶＰ组术中无大出血及经尿道前列腺电切综合征（ＴＵＲＳ）发生，需输血者仅１例。ＴＵＲＰ组３例发生ＴＵＲＳ，输血１４例。比较结果：ＴＶＰ能达到与ＴＵＲＰ完全相同的治疗效果，且并发症少，价格相对较低，近期效果满意。
Twenty-four patients with symptomatic BPH underwent transurethral electrovaporization (TVP) and transurethral resection of the prostate (TURP). The results showed that in 120 TVP surges, the IPSS decreased from 20.9 preoperatively to 5.1 postoperatively at 3 months (P <0.001), and the maximum flow rate increased from 10.6 mL / s increased to 19.2 ml / s (P <0.01). In the TURP group, the IPSS decreased from 21.2 preoperatively to 5.2 postoperatively at 3 months (P <0.001), and the maximum urinary flow increased from 10.2 to 19.4 mL / s ( P <0.01). There was no significant difference between the two groups (P> 0.05). The average indwelling catheter time: TVP group 26.5 hours, TURP group 50.7 hours, there was a significant difference (P <0.01). The incidence of postoperative impotence was 2.4% in TVP group and 14.5% in TURP group (P <0.05). In TVP group, there was no major bleeding and transurethral resection of prostate (TURS), only 1 patient needed blood transfusion. TURS occurred in 3 cases and 14 cases were transfused. Comparing the results: TVP can achieve exactly the same therapeutic effect as TURP with fewer complications and relatively low prices, with satisfactory results in the near future.